Prof Saye Khoo MB,BS, MRCP, DTM&H, FRCP, MD, Diploma in Epidemiology

Professor(Clin, Hcc) Molecular and Clinical Pharmacology

    Biography

    Personal Distinctions

    • Interaction between HCV and HIV drugs: present status and future development (Invitation to Speak, Nordic HIV Physicians 2011)
    • Pharmacogenetics of HIV (Invitation to Speak, Wellcome PKPD Network 2011)
    • TDM in guidelines and clinical practice (Invitation to Speak, Univ of Torino 2011)
    • Treating HIV & comorbidity: drug interactions (Invitation to Speak, European AIDS Clincial Society 2011)
    • HIV-TB interactions (Invitation to Speak, Karolinska Instituet 2011)
    • Managing Drug-Drug interactions (Invitation to Speak, HIV Medical Association of India 2011)
    • PK-PD Modelling & Personalised Medicine (Invitation to Speak, Deutsch-Österreichischer AIDS-Kongress 2011)
    • HIV Pharmacology (Invitation to Speak, Advanced Course in HIV Medicine 2011)
    • HIV for Generalists (Invitation to Speak, Royal College of Physicians 2010)
    • Pharmacology Case Discussion (Chair) (Invitation to Speak, BHIVA 2010)
    • Drug interactions related to HIV-TB co-infected patients (Invitation to Speak, 3rd International workshop on Clinical Pharmacology of TB drugs 2010)
    • Epidemiology of Drug Interactions (Invitation to Speak, 10th international congress on HIV and Drug Therapy in HIV Infection 2010)
    • Understanding pharmacokinetics and therapeutic drug monitoring of current antiretrovirals in childre (Invitation to Speak, CHIVA 2010)
    • Clinical & Pharmacological aspects of Neuropsychiatric symptoms in HIV (Invitation to Speak, 3rd International Simposium on Psychiatry & HIV 2010)
    • Relevance of ARV PK in the CNS (Invitation to Speak, 10th international congress on HIV and Drug Therapy in HIV Infection 2010)
    • PK-PD modelling in HIV (Invitation to Speak, Wellcome Trust's Frontiers Meetings programme 2010)
    • TDM in guidelines and clinical practice (Invitation to Speak, University of Torino, Italy 2010)
    • What TDM can and cannot tell you (Invitation to Speak, 4th Residential Course in Clinical Pharmacology of Antiretrovirals, University of Torino, Italy 2009)
    • Interactions between HIV and Malaria (Invitation to Speak, 10th International Workshop on Clinical Pharmacology of HIV Therapy, Amsterdam 2009)
    • Drug interactions which really matter (Invitation to Speak, 9th International Congress on Drug Therapy in HIV Infection, Glasgow 2008)
    • Session Chair & Organising Committee (Invitation to Speak, 1st International Workshop on Clinical Pharmacology of Tuberculosis Drugs, Toronto 2008)
    • Pharmacology of HIV Treatment Failure (Invitation to Speak, Dept of Infectious Diseases, Tan Tock Seng Hospital, Singapore 2008)
    • Pharmacology, metabolism and transport of HIV drugs into viral reservoirs (Invitation to Speak, HIV DART 2008, Frontiers in Drug Development in Antiretroviral Therapies, Puerto Rico 2008)
    • Interactions between HIV and Hepatitis C (Invitation to Speak, 2nd International Workshop on Clinical Trial Design: Experimental HCV Drugs for HIV/HCV Coinfected People, Spain 2008)
    • Pharmacogenetics and HIV Treatment (Invitation to Speak, GSK Sponsored Meeting, London 2007)
    • HIV-TB Drug Interactions (Invitation to Speak, Inter TB Conference, St George's Hospital 2007)
    • Drug Interactions (Invitation to Speak, Human Healthcare Research Foundation / Grant Medical College, Mumbai, India 2007)
    • Therapeutic Drug Monitoring (Invitation to Speak, Boehringer Ingelheim European Investigator's Meeting, Milan 2007)
    • Interactions between Malaria and HIV (Invitation to Speak, EDCTP Clinical Pharmacology Network Meeting, Kampala 2007)
    • Drug Interactions & Roundtable Discussion (Invitation to Speak, Mumbai, India 2007)
    • What TDM can and cannot tell you (Invitation to Speak, 3rd Residential Course in Clinical Pharmacology of Antiretrovirals, Uni of Torino, Italy 2007)
    • Drug interactions (Invitation to Speak, Security & Simplicity, Abbot Symposium, Lake Maggiore, Italy 2006)
    • Pharmacokinetic considerations for antiretroviral therapy (Invitation to Speak, Gilead 2006)
    • Choosing a nucleoside backbone (Invitation to Speak, Serviço de Doenças Infecciosas, Hospital de Santa Maria, Lisboa, Lisbon, Portugal 2006)
    • HIV Lipodystrophy Syndrome (Chair & Speaker) (Invitation to Speak, British Association for Sexual Health & HIV 2006)
    • The pharmacology of HIV Treatment Failure (Invitation to Speak, Institute of Virology, UCL, 2006)
    • (Chair & speaker) Once-daily Treatment – What’s in a name? (Invitation to Speak, British HIV Association 2006)
    • Therapeutic Drug Monitoring (Invitation to Speak, University of Turin 2006)
    • Update on therapeutic drug monitoring- a critical review (Invitation to Speak, European HIV Drug Resistance Workshop 2006)
    • Drug Interactions (Invitation to Speak, University of Turin. 2005)
    • HIV lipodystrophy (Invitation to Speak, British Association of Sports Medicine 2005)
    • HIV Clinical Guidelines (Invitation to Speak, European Congress of Chemotherapy 2005)
    • Pros and Cons of Once-daily Regimens (Invitation to Speak, Gilead Europe Ltd 2005)
    • Pharmacokinetic considerations for antiretroviral therapy (Invitation to Speak, Gilead (Europe) 2005)
    • First line regimens- a PK perspective (Invitation to Speak, National AIDS Manual 2005)
    • Therapeutic Drug Monitoring (Invitation to Speak, British Association of Sexual Health & HIV 2005)

    Untitled Document